BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17110929)

  • 1. MDMX regulation of p53 response to ribosomal stress.
    Gilkes DM; Chen L; Chen J
    EMBO J; 2006 Nov; 25(23):5614-25. PubMed ID: 17110929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of MDMX in the regulation of p53 response to ribosomal stress.
    Gilkes DM; Chen J
    Cell Cycle; 2007 Jan; 6(2):151-5. PubMed ID: 17327702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
    Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
    Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
    Bursać S; Brdovčak MC; Pfannkuchen M; Orsolić I; Golomb L; Zhu Y; Katz C; Daftuar L; Grabušić K; Vukelić I; Filić V; Oren M; Prives C; Volarevic S
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20467-72. PubMed ID: 23169665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
    Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
    Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.
    Ling X; Xu C; Fan C; Zhong K; Li F; Wang X
    Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
    Gao C; Xiao G; Piersigilli A; Gou J; Ogunwobi O; Bargonetti J
    Breast Cancer Res; 2019 Jan; 21(1):5. PubMed ID: 30642351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
    Lemos A; Leão M; Soares J; Palmeira A; Pinto M; Saraiva L; Sousa ME
    Med Res Rev; 2016 Sep; 36(5):789-844. PubMed ID: 27302609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells.
    Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I
    Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction.
    Sun XX; Dai MS; Lu H
    J Biol Chem; 2007 Mar; 282(11):8052-9. PubMed ID: 17242401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MdmX on Mdm2-mediated downregulation of pRB.
    Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M
    FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive mdmx expression during cell growth, differentiation, and DNA damage.
    Jackson MW; Berberich SJ
    DNA Cell Biol; 1999 Sep; 18(9):693-700. PubMed ID: 10492400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.
    Dai MS; Lu H
    J Biol Chem; 2004 Oct; 279(43):44475-82. PubMed ID: 15308643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.
    Biderman L; Poyurovsky MV; Assia Y; Manley JL; Prives C
    Mol Cell Biol; 2012 Apr; 32(7):1214-25. PubMed ID: 22290440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
    Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
    Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.